Levels of inflammatory cytokines and plasma cortisol in respiratory syncytial virus bronchiolitis;Aumento de interleuquinas proinflamatorias y de cortisol plasmático en bronquiolitis por virus respiratorio sincicial: Relación con la gravedad de la infección

Revista Medica de Chile

Volumn 141, Issue 5, 2013, Pages 574-581

  Díaz, Patricia V ^a   Gaggero, Aldo A ^a,b   Pinto, Ricardo A ^b   Mamani, Rossana ^b   Uasapud, Paola A ^c   Bono, María Rosa ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Servicio de Salud Metropolitano Norte   (Chile)

Author keywords

Bronchiolitis; Interleukins; Respiratory syncytial virus infection; Viral

Indexed keywords

HYDROCORTISONE; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; BRONCHIOLITIS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; NASOPHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEVERITY OF ILLNESS INDEX; VIROLOGY;

BRONCHIOLITIS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCORTISONE; INFANT; INTERLEUKINS; MALE; NASOPHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883148657     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872013000500004     Document Type: Article

References (37)

1. Avendaño LF, Palomino MA, Larrañaga C. Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile. J Clin Microbiol 2003; 41: 4879-82.
2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory Syncytial Virus infection in elderly and high risk adults. N Engl J Med 2005; 352: 1749-59.
3. Hoffman SJ, Laham FR, Polack FP. Mechanism of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes and Infection 2004; 6: 762-7.
4. Duncan CB, Walsh EE, Peterson DR, Lee FE-H, Falsey AR. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults J Infect Dis 2009; 200: 1242-46.
5. Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years Virus Research 2011; 162: 80-99.
6. Sheeran P, Jafri H, Carubelli C, Saavedra J, Krisher K, Sánchez PJ, Ramilo O. Elevated cytokine concentrations in the nasopharyngheal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999; 18: 115-22.
7. McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL. Pro and anti-inflammatory responses in respiratory syncytial virus bronquiolitis. Eur Respir J 2004; 23: 106-12.
8. Faber TE, Groen H, Welfing M, Jansen KJG, Bont LJ. Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J Med Virol 2012; 84: 1084-8.
9. Openshaw PJM, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microb Rev 2005; 18: 541-55.
10. Arnold R, König B, Gallati H, Werchau H, König W. Interleukin-8, Interleukin-6, and soluble tumor necrosis factor receptor type release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1995; 82: 364-72.
11. Fonceca AM, Flanagan BF, Trinick R, Smyth RL, McNamara PS. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection Thorax 2012; 67: 42-8.
12. Díaz P, Calhoun WJ, Hinton K, Avendaño LF, Gaggero A, Simon V, et al. Differential effects of respiratory syncytial virus and adenovirus on mononuclear cell cytokine responses. Am J Respir Crit Care Med 1999; 160: 1157-64.
13. Roman M, Calhoun WJ, Hinton KM, Avendaño LF, Simon V, Escobar AM, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2 like response. Am J Respir Crit Care Med 1997; 156; 160: 1263-8.
14. Aberle JH, Aberle SW, Rebhandl W, Pracher E, Kundi M, Popow-Kraupp T. Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol 2004; 137: 146-50.
15. Bont L, Heijnen CJ, Kavelaars A, Van Aalderen WMC, Brus M, Draaisma JT, et al. Peripheral blood cytokine responses and disease severity in respiratory virus bronchiolitis Eur Respir J 1999; 14: 144-9.
16. Leggs JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and Type-2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168: 633-9.
17. Pinto R, Arredondo SM, Bono MR, Gaggero AA, Díaz PV. T helper 1/Thelper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increase endogenous plasma cortisol Pediatrics 2006; 117e 878-86.
18. Larrañaga CL, Ampuero SL, Luchsinger VF, Carrión FA, Aguilar NV, Morales PR, et al. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus Ped Infect Dis J 2009 28; 867-73.
19. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendaño LF, Sanchez K, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007; 195: 1126-36.
20. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypoyhalamic-pituitary-adrenal revolving axis. J Neuroimmunol 2002; 133: 1-19.
21. Bethin KE, Vogt SK, Muglia LJ. Interleukin-6 is an essential, corticotrophin releasing hormone-independent, stimulator of the adrenal axis during immune system activation. PNAS 2000; 16: 9317-22.
22. Silverman MN, Miller AH, Biron CA, Pearce BD. Characterization of an Interleukin-6 and Adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology 2004; 145: 3580-9.
23. Steensberg A, Fisher CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10 and cortisol in humans. Am J Physiol Endocrinol Metab 2003; 285: E433-E7.
24. Smyth RL, Mobbs KJ, ÓHea U, Ashby D, Hart CA. Respiratory syncytial virus bronchiolitis: disease severity. Interleukin-8 and virus genotype. Ped Pulm 2002; 33: 339-46.
25. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. Broncoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003; 88: 922-6.
26. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, et al. Immunpathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 2007; 195: 1532-40.
27. Emboriadou M, Hatzistilianou M, Magnisali C, Sakelaropoulou A, Exintari M, Conti P, et al. Human neutrophil elastase in RSV bronchiolitis. Ann Clin Lab Sci 2007; 37: 79-84.
28. Yasui K, Baba A, Iwasaki Y, Kubo T, Aoyama K, Mori T, et al. Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Ped Int 2005; 47: 190-5.
29. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hertshenson MB, et al. IL-17 induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011; 179: 248-58.
30. Midulla F, Villani A, Panuska JR, Dab I, Kolls JK, Merolla R, et al. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis 1993; 168: 1515-9.
31. Puthothu B, Bierbaum S, Kopp MV, Forster J, Heinze J, Weckmann M, et al. Association of TNF-α with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol 2009; 20: 157-63.
32. Emers MJ, Rovers MM, van Woensel JB, Kimpen JL, Bont LJ, RSV corticosteroid study group. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomized double blind placebo controlled trial. BMJ 2009; 338: b897.
33. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; 3: CD004878.
34. Bonville CA, Mehta PA, Krilov LR, Rosenberg HF, Domachowske JB. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effect of hydrocortisone Cel Immunol 2001; 213: 134-40.
35. Hinsey A, Alexander J, Corry J, Adams KM, Clagget AM, Traylor ZP, et al. Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation. Endocrinology 2011; 152: 483-94.
36. Díaz PV, Pinto RA, Mamani R, Uasapud P, Bono MR, Gaggero A, et al. Increased expression of the glucocorticoid receptor β in infants with RSV bronchiolitis. Pediatrics 2012; 130; e804-11.
37. Lee EF-H, Walsh EE, Falsey AR. The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness. Chest 2011; 140: 1155-61.